Drug Patents owned by Biofrontera

1. Drug name - AMELUZ

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11235169 BIOFRONTERA Illumination device for photodynamic therapy, method for treating a skin disease and method for operating an illumination device Oct, 2040

(18 years from now)

Drugs and Companies using AMINOLEVULINIC ACID HYDROCHLORIDE ingredient

Treatment: Topical lesion-directed and field-directed treatment of actinic keratosis of the face and scalp with photodynamic therapy by positioning an illumination device in an appropriate distance and illuminating the treatment area with narrowband red light

Dosage: GEL;TOPICAL

More Information on Dosage
Strength Dosage Availability
10% GEL;TOPICAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.